A. Ettrup, M. Palner, et al.: Radiosynthesis and Evaluation of 11C-CIMBI-5 as a 5-HT2A Receptor Agonist Radioligand for PET. In: Journal of Nuclear Medicine. 51, 2010, S. 1763–1770, doi:10.2967/jnumed.109.074021.
Nichols DE, Frescas SP, Chemel BR, Rehder KS, Zhong D, Lewin AH: High Specific Activity Tritium-Labeled N-(2-methoxybenzyl)-2,5-dimethoxy-4-iodophenethylamine (INBMeO): A High Affinity 5-HT2A Receptor-Selective Agonist Radioligand. In: Bioorganic & Medicinal Chemistry. 16. Jahrgang, Nr.11, Juni 2008, S.6116–23, doi:10.1016/j.bmc.2008.04.050, PMID 18468904, PMC 2719953 (freier Volltext).